Synonyms: Factive® | LB20304 | SB 265805
gemifloxacin is an approved drug (FDA (2003))
Compound class:
Synthetic organic
Comment: Gemifloxacin is a fluoroquinolone antibacterial compound with potent activity against both Gram-negative and Gram-positive microorganisms [2-3].
|
|
References |
1. European Medicines Agency.
Withdrawal Assessment Report for Factive. Accessed on 19/03/2023. Modified on 19/03/2023. https://www.ema.europa.eu/en/documents/withdrawal-report/withdrawal-assessment-report-factive_en.pdf |
2. Hong CY, Kim YK, Chang JH, Kim SH, Choi H, Nam DH, Kim YZ, Kwak JH. (1997)
Novel fluoroquinolone antibacterial agents containing oxime-substituted (aminomethyl)pyrrolidines: synthesis and antibacterial activity of 7-(4-(aminomethyl)-3-(methoxyimino)pyrrolidin-1-yl)-1-cyclopropyl-6- fluoro-4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxylic acid (LB20304). J Med Chem, 40 (22): 3584-93. [PMID:9357525] |
3. Oh JI, Paek KS, Ahn MJ, Kim MY, Hong CY, Kim IC, Kwak JH. (1996)
In vitro and in vivo evaluations of LB20304, a new fluoronaphthyridone. Antimicrob Agents Chemother, 40 (6): 1564-8. [PMID:8726042] |